G
Günther G. Steger
Researcher at Medical University of Vienna
Publications - 243
Citations - 11875
Günther G. Steger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 41, co-authored 238 publications receiving 10859 citations. Previous affiliations of Günther G. Steger include University of Vienna.
Papers
More filters
Journal ArticleDOI
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy
Matti Aapro,Alessandra Fabi,Franco Nolè,M. Medici,Günther G. Steger,C. Bachmann,S. Roncoroni,Fausto Roila +7 more
TL;DR: In patients treated with a single injection of palonosetron on day 1, reducing dexamethasone is an option that is not associated with significant reduction in antiemetic control during the 5-day period or an impact on patient functioning.
Journal ArticleDOI
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid
Miguel Martin,Richard C. Bell,Hugues Bourgeois,Adam Brufsky,Ingo Diel,Alexandru Eniu,Lesley Fallowfield,Yasuhiro Fujiwara,Jacek Jassem,Alexander H.G. Paterson,Diana Ritchie,Günther G. Steger,Alison Stopeck,Charles L. Vogel,Michelle Fan,Qi Jiang,Karen Chung,Roger Dansey,Ada Braun +18 more
TL;DR: Denosumab was superior to zoledronic acid in reducing bone-related complications of metastatic breast cancer and maintained HRQoL, providing an efficacious, well-tolerated treatment option for patients with bone metastases from breast cancer.
Journal ArticleDOI
Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
José Baselga,Milvia Zambetti,Antoni Llombart-Cussac,Georgy M. Manikhas,Ernst Kubista,Günther G. Steger,A. Makhson,Sergei Tjulandin,Heinz Ludwig,Mark Verrill,Eva Ciruelos,Suzanne Egyhazi,Li-An Xu,Kim E. Zerba,Hyerim Lee,Edwin A. Clark,Susan M. Galbraith +16 more
TL;DR: In this article, the authors evaluated the efficacy and safety of ixabepilone as a neoadjuvant therapy for invasive breast cancer not amenable to breast conservation surgery, using gene expression data from 134 patients.
Journal ArticleDOI
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial
Florian Fitzal,Vesna Bjelic-Radisic,Michael Knauer,Günther G. Steger,Michael Hubalek,Marija Balic,Christian Singer,Rupert Bartsch,Peter Schrenk,Lidija Soelkner,Richard Greil,Michael Gnant +11 more
TL;DR: The prospective phase III trial ABCSG-28 (POSYTIVE) could not demonstrate an OS benefit for surgical resection of the primary in breast cancer patients presenting with de novo stage IV disease.
Journal ArticleDOI
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Walter Reinisch,Martin Willheim,M Hilgarth,Christoph Gasche,Robert M. Mader,S Szepfalusi,Günther G. Steger,R Berger,Klaus Lechner,George Boltz-Nitulescu +9 more
TL;DR: The results indicate that sCD23 is a highly sensitive and specific parameter with prognostic potential for B-CLL, which may be used as a tumor marker and may help to assess disease activity.